French Energy Services Stock News

Sanofi (ENXTPA:SAN) received FDA approval in the US for Dupixent as the first designated treatment for allergic fungal rhinosinusitis. EU regulators issued a positive opinion for Dupixent in young children with chronic spontaneous urticaria. The EU also gave a positive opinion for Acoziborole Winthrop, a single dose oral treatment for sleeping sickness in adults and adolescents. For Sanofi, these decisions touch both its core immunology franchise and its long running work in neglected...

Event context and current performance snapshot Robertet (ENXTPA:RBT) has been drawing attention after recent price moves, with the share price last closing at €825. Recent returns show a 1 day decline of 0.24%, a 7 day decline of 4.73%, and a month decline of 1.43%. See our latest analysis for Robertet. Recent selling pressure has pulled the 90 day share price return to an 8.74% decline and the year to date share price return to a 6.14% decline. The 1 year total shareholder return is 2.12%,...

Why the 2025 results and 2028 guidance matter for investors 74Software (ENXTPA:74SW) has drawn investor attention after releasing its 2025 full year results alongside fresh guidance for 2028, combining recent performance data with a clearer view of its longer term financial ambitions. On the reported figures, sales for 2025 came in at €707.22 million, while net income was €40.76 million. Basic earnings per share from continuing operations were €1.39, with diluted earnings per share at...

Viridien Société anonyme (ENXTPA:VIRI) has moved into focus after its recent earnings showed higher net income alongside lower sales, together with the rebrand from CGG that highlights its focus on Earth data and sensing. See our latest analysis for Viridien Société anonyme. Those earnings and the CGG rebrand sit against a strong recent run, with a 90 day share price return of 35.29% at €122.1 and a 1 year total shareholder return of 100.13%. This hints that momentum has been building rather...

DBV Technologies recently presented additional positive data from its successful Phase 3 VITESSE trial of the VIASKIN Peanut Patch for peanut-allergic children aged 4 to 7 at the 2026 AAAAI Annual Meeting in Philadelphia. The data showed clinically meaningful increases in the eliciting dose for treated children versus placebo, highlighting both potential protection against reactions and the risks of remaining untreated. Next, we will examine how these Phase 3 VITESSE results, particularly...

Why Planisware SAS (ENXTPA:PLNW) Is Back on Investors’ Radar Planisware SAS (ENXTPA:PLNW) has caught investor attention after issuing 2026 revenue guidance targeting low double digit growth in constant currencies and proposing a €0.36 dividend per share for 2025, a 16.1% year on year increase. The proposed €0.36 payout represents a 50% distribution of 2025 earnings, so the company is pairing its growth objectives with a commitment to return half of its profits to shareholders. See our latest...

Worldline FY 2025 results: deep losses meet modest revenue base Worldline (ENXTPA:WLN) has reported fresh numbers for FY 2025, with first half revenue of €2,204.7 million and basic EPS at a loss of €15.05. This compares with a trailing twelve month loss of €18.35 per share on €4,029.9 million of revenue. Over recent periods the company has seen revenue move from €2,368.3 million in the second half of 2023 to €2,288.9 million in the first half of 2024, then to €2,204.7 million in the first...

Ipsos (ENXTPA:IPS) has launched a €100 million share buyback programme, putting extra attention on how management is choosing to return capital and what that might mean for existing shareholders. See our latest analysis for Ipsos. The buyback follows a series of announcements, including a proposed €2.00 per share dividend, recent full year 2025 results, and changes in senior leadership and technology roles, with the share price currently at €36.92. The 30 day share price return of 11.81% and...

Société BIC (ENXTPA:BB) is back in focus after releasing its 2025 full year results, reporting lower sales, a reduced net income of €86 million, basic EPS of €2.10, and a lower dividend. See our latest analysis for Société BIC. The earnings and dividend cuts appear to be weighing on sentiment, with the share price at €54.1 and a 90 day share price return of 16.09% contrasting with a 1 year total shareholder return decline of 4.43% and a 5 year total shareholder return of 37.34%. If this...

EssilorLuxottica Société anonyme (ENXTPA:EL) in focus after recent share performance EssilorLuxottica Société anonyme (ENXTPA:EL) is drawing attention after a recent share price slide, with the stock showing negative returns over the past week, month and past 3 months. Against this backdrop, investors are weighing the company’s €28,491.0m in revenue and €2,315.0m in net income alongside its longer term total returns over 3 and 5 years. See our latest analysis for EssilorLuxottica Société...

New LNG Carrier Order Puts GTT’s Core Technology Back in Focus Gaztransport & Technigaz (ENXTPA:GTT) has just secured a new order from Samsung Heavy Industries for the design of cryogenic tanks on a 180,000 cubic meter LNG carrier, using its Mark III Flex membrane containment system. The vessel is scheduled for delivery in 2028. This contract follows earlier LNG carrier orders, including a series from Hanwha Ocean, and keeps attention on how recurring projects feed into GTT’s order book and...

On February 26, 2026, Viridien Société anonyme held a board meeting and reported fourth-quarter and full-year 2025 results, with quarterly sales of US$312 million and net income of US$52 million, and full-year sales of US$1,070.5 million alongside net income of US$71.1 million. The company’s ability to grow net income and earnings per share year-on-year despite lower sales highlights a focus on improving profitability and cost efficiency. We’ll now examine how Viridien’s higher net income...

GL Events (ENXTPA:GLO) has put fresh numbers on the table for FY 2025, reporting first half revenue of €886.7 million and basic EPS of €1.69, with trailing 12 month revenue of about €1.7 billion and EPS of €2.93 setting the broader backdrop. Over recent periods, revenue has moved from €813.8 million in 2H 2024 to €886.7 million in 1H 2025, while EPS stepped from €1.24 and €1.27 in the two halves of 2024 to €1.69 in the latest half. This gives investors a clear view of how the top and bottom...

Intro Atos (ENXTPA:ATO) has just reported its FY 2025 results with first half revenue of €4.0b and a basic EPS loss of €37.36, alongside net income excluding extra items of a €696m loss. Over recent reporting periods the company has seen revenue move from €5.0b in the first half of 2024 to €4.6b in the second half of 2024 and €4.0b in the first half of 2025, while EPS has swung from a €174,754.66 loss in early 2024 to a €1,531.47 gain in late 2024 before landing at a €37.36 loss most...

Sopra Steria Group (ENXTPA:SOP) is back in focus after reporting 2025 earnings that combined lower sales with higher net income and earnings per share, along with a proposed dividend increase for shareholders. See our latest analysis for Sopra Steria Group. The share price reaction has been positive around these results, with a 1-day share price return of 3.86% and a 7-day share price return of 4.65% at €137.3. However, the year-to-date share price return of an 8.95% decline and the 1-year...

JCDecaux (ENXTPA:DEC) is back on investor radars after its latest reported annual figures, with revenue of €3.7b and net income of €240.4m, prompting fresh questions about how the stock is currently priced. See our latest analysis for JCDecaux. The latest figures land after a softer patch for the share price, with a 7 day share price return of 5.36% and a 1 year total shareholder return of 0.95%. This suggests recent momentum has cooled compared with the longer trend. If JCDecaux’s recent...

Renault, through its EV and software unit Ampere, has agreed a Joint Development Agreement with Basquevolt to work on next generation lithium metal based batteries. The partnership focuses on developing and validating polymer electrolyte batteries for use in future Renault electric vehicles. The project aims to improve EV range, efficiency, and manufacturing processes compared with current battery technologies. For investors tracking ENXTPA:RNO, this move comes at a time when the share...

Planisware SAS, listed as ENXTPA:PLNW, has launched a significant share buyback program approved by its shareholders. The program includes a mandate that allows for the potential cancellation of repurchased shares. This move directly affects the company’s capital structure and the distribution of value among existing shareholders. Planisware SAS operates in project and portfolio management software, a segment that sits at the intersection of enterprise IT, digital transformation and long...

Compagnie de Saint-Gobain (ENXTPA:SGO) has come under pressure recently, with the share price showing negative returns over the past month and past 3 months. This is prompting investors to reassess how the stock now lines up with fundamentals. See our latest analysis for Compagnie de Saint-Gobain. At around €74.06, the recent 14.12% 7 day and 15.24% 30 day share price declines extend a wider year to date share price return of 14.89%. This sits against a 1 year total shareholder return of...

If you are trying to figure out whether DBV Technologies is actually good value at around €3.77 per share, you are in the right place. The stock has had a volatile run, with a 4.9% return over the last 7 days, a 4.3% decline over 30 days, a 15.3% return year to date, and a 363.7% return over the past year, which can mean both opportunity and higher perceived risk. Recent news coverage has focused on DBV Technologies as a French biopharma working on allergy treatments, with investors paying...

Exosens (ENXTPA:EXENS) is in focus after its US subsidiary, Photonis Defense Inc., secured a firm-fixed-price IDIQ contract with the U.S. Army for binocular night observation devices, along with fresh earnings, dividend, and guidance updates. See our latest analysis for Exosens. Exosens’ 1 month share price return of 23.02% and 90 day share price return of 41.33% to €63.6 suggest momentum has picked up. The 1 year total shareholder return of 95.19% reinforces how recent contract wins,...

Airbus (ENXTPA:AIR) has secured its largest direct order from Kazakhstan's Air Astana Group for 25 A320neo Family aircraft. The deal supports fleet renewal and capacity expansion plans for Air Astana Group in Central Asia. The Chinese government has signaled interest in a potential purchase of up to 120 Airbus aircraft. The prospective China order coincides with efforts to deepen economic ties between China and Germany and could influence Airbus production planning. Airbus (ENXTPA:AIR) is a...

Interparfums (ENXTPA:ITP) is back in focus after its Q4 2025 earnings call, where the company reported full year 2025 results and confirmed its annual dividend of €1.05 per share. See our latest analysis for Interparfums. The recent earnings update and confirmed dividend come as Interparfums’ share price has eased, with a 30 day share price return decline of 10.35% and a 1 year total shareholder return decline of 38.50%, pointing to fading momentum despite continued revenue generation. If you...

Wondering if Argan’s current share price reflects its true worth, or if the market is missing something you can use to your advantage? The stock recently closed at €65.90, with a 7.3% decline over the past week, a 0.6% decline over the last month, but a 9.7% gain over the past year that may be catching some investors’ attention. Recent news coverage around Argan has focused less on headlines and more on its standing within the French real estate sector. This has prompted questions about how...